Investors

Top

Investor relations

We use innovative science to pursue novel treatments that address important medical challenges in neurological, autoimmune and rare diseases. Our therapies for multiple sclerosis are just the beginning.

2017 ANNUAL REPORT

Stock information

Find Biogen’s current and historical stock information. 

NASDAQ: BIIB (Common Stock)

  • Volume
  • Today's Open $
  • Previous Close $
  • 52 Week High $
  • 52 Week Low $